Yubo International Biotech Limited
YBGJ
$0.06
-$0.01-14.29%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 50.12% | -10.10% | -39.81% | 27.08% | -8,312.70% |
| Total Depreciation and Amortization | -12.40% | 5.22% | -1.08% | -59.60% | 144.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -22.95% | -134.29% | 597.20% | -- | -- |
| Change in Net Operating Assets | -224.88% | 282.38% | -46.66% | 255.51% | -144.29% |
| Cash from Operations | -907.24% | 51.77% | -59.47% | 78.44% | -11,049.02% |
| Capital Expenditure | -- | -- | 200.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -100.00% | -55.49% | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 200.00% | -- | -- |
| Cash from Investing | -100.00% | -67.41% | 473.33% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 202.36% | -85.44% | 77.96% | -- | -- |
| Cash from Financing | 4,267.72% | -85.44% | 77.96% | -86.86% | -- |
| Foreign Exchange rate Adjustments | -671.38% | 121.64% | -239.38% | 155.37% | -3,624.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -433.33% | 100.61% | -197.24% | 4,509.09% | 1,000.00% |